Your session is about to expire
← Back to Search
Brain MRI Analysis for Congenital Heart Disease
Study Summary
This trial will use MRI to study how d-TGA affects the brain, and how genes may play a role in modulating that effect.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a healthy adult who can consent to an MRI and some brain function tests.I cannot complete study forms by myself due to intellectual impairment.You cannot speak and read English well.You were part of a previous study at Boston Children's Hospital when you were a child.You cannot have an MRI if you have metal in your body, feel very scared in small spaces, have had mental health issues, brain injury, or brain surgery before.
- Group 1: Brain MRI
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is eligible to partake in this research trial?
"This research study seeks 225 participants with congenital heart disease (CHD) aged between 24 to 35 years old. Most critically, applicants need to have taken part in the Boston Circulatory Arrest, pH and Hematocrit studies at Boston Childrens Hospital as children (n~300). Additionally, normally-developed age-matched adults able to give informed consent must also be included for MRI scans and limited IQ testing alongside more specialized neuropsychological tests which lack a normative reference."
How many participants are contributing to this trial's findings?
"Affirmative, according to records on clinicaltrials.gov the trial is still enrolling participants. This study was first advertised on July 1st 2022 and last updated 19th September of the same year. The aim is to recruit 225 patients from one medical centre."
Is the research team currently engaging new participants for this experiment?
"Affirmative. Clinicaltrials.gov points out that the trial, which was launched on July 1st 2022 and recently revised on September 19th 2022, is actively recruiting 225 participants from a single medical site."
Is there an upper age limit for those eligible to participate in this trial?
"This research aims to include individuals between 24 and 35 years of age."
Share this study with friends
Copy Link
Messenger